Summary:

«Market watchers say 2023 is setting up to be even tougher than 2022 for digital health executives and investors.»

«Health systems, which represent a major segment of digital health buyers, are losing billions of dollars and looking to cut expenses. Digital health companies that cater directly to consumers face the dual challenge of inflation and a potential recession, which has led to a shift in strategy toward targeting enterprise customers.»

«But optimism isn’t completely out the window. Pharmaceutical corporations, insurance companies and self-insured employers are still active digital health adopters, and health systems aren’t going to cut back entirely. Here are three areas of health technology that generated buzz among industry stakeholders this year and could withstand economic turbulence in 2023.»

Article written by GABRIEL PERNA

27|12|2022

Source:

Digital Health

https://digitalhealth.modernhealthcare.com/technology/virtual-reality-clinical-ai-decentralized-trials-2022-2023